Politico December 6, 2024
By Ben Leonard and Chelsea Cirruzzo

With help from Daniel Payne, Kelly Hooper and Carmen Paun

Driving The Day

THE REGS ARE COMING — The first Trump administration took or mulled a slew of regulatory actions in its final weeks, including significant changes to Medicaid, term limits for top federal health scientists and a plan to lower drug prices by tying government payments for medicines to lower prices paid abroad.

“The Trump administration opened up the fire hose in [its] last month,” said Jeffrey Davis, health policy director at McDermott+ Consulting.

A similar flood of Biden administration regulatory actions could be forthcoming, though the incoming Congress or the Trump administration could overturn or discard them — Biden, for example, pulled Trump’s drug price proposal and Medicaid...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Regulations
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
KFF Health Tracking Poll: Public Weighs Health Care Spending and Other Priorities for Incoming Administration
MedPAC wants Medicare physician reimbursement tied to Medicare Economic Index

Share This Article